echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > JAMA Express. Multiple reviews of the high mortality rate in the United States in the 2020 new crown pandemic.

    JAMA Express. Multiple reviews of the high mortality rate in the United States in the 2020 new crown pandemic.

    • Last Update: 2020-10-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Two new reports published by JAMA provide the latest estimates of mortality in the United States associated with the New Coronavirus (COVID-19) pandemic.
    's first Woolf and colleagues updated their analysis of "excessive" deaths related to COVID-19 and other causes from March 1 to August 1, 2020, "in which 133,6561 deaths were reported in the United States, an estimated 20 percent increase over the expected number of deaths, suggesting an additional 225,530 deaths."
    about 67% of all additional deaths can be attributed directly to COVID-19, while additional deaths attributable to other causes are usually associated with pandemics.
    More importantly, Woolf et al. predict that more than 400,000 additional deaths are likely to occur throughout 2020, as deaths from certain causes (such as car accidents) may decrease, while deaths from others (such as myocardial infarction) may increase.
    these deaths are a true reflection of the price people pay for the new crown epidemic in 2020.
    those deaths far outnumbered those in the United States as a result of certain armed conflicts, such as the Korean and Vietnam Wars, and surpassed those killed in the 2009 HINI pandemic, which neared world war II.
    Bilinski and Emanuel compared the United States with oecdes with countries with a population of more than 5 million, and found that "since the beginning of the new crown pandemic, the United States ranks third among countries with moderate or high mortality rates (n=8;5-25/100,000) or high mortality rates (n=7;gt;25/100,000) countries, with 71.6 deaths per 100,000 people."
    Bilinski and Emanuel also noted that by September 2020, the United States had experienced high COVID-19-related and high all-cause mortality rates.
    the peak in early spring, the united States still has higher mortality rates from COVID-19 and a variety of causes than other countries with high COVID-19 mortality rates.
    addition, three reviews and a JAMA editor reviewed mental health, financial and variance issues related to the new crown pandemic.
    Simon and his colleagues said, "It is critical that for each death, an estimated nine family members will be affected, such as long-term grief or post-traumatic stress disorder."
    in short, about 3.5 million people may have major mental health needs.
    , this does not include the thousands of health care workers in hospitals and nursing homes who have witnessed a large number of COVID-19-related deaths.
    Cooper and Williams commented on the stubborn and seemingly unresolved inherent differences in the U.S. and U.S. health care systems and called for a return to fairness and justice.
    unfortunately, this problem is not new, but the COVID-19 pandemic has once again highlighted and further exacerbated the health, social and economic disparities inherent in this group of people of color.
    , "The COVID-19 pandemic is the biggest threat to prosperity in the United States since the Great Depression of 1929," said Cutler and Summers.
    estimated that the total financial costs of the pandemic (loss of economic output and health-related losses) were $16 trillion, or about 90 per cent of annual GROSS.
    the estimated economic damage caused by COVID-19 is a staggering figure, but largely avoidable and could rebound in the coming years.
    JAMA editor Fineberg highlighted the key ideas of these and others' views and the veracity of data on excessive deaths associated with COVID-19.
    , Fineberg also stressed that "a strong, sustained, multi-pronged and consistent response is a necessary requirement now and a national priority."
    "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.